GLP-1 Agonists: Heart & Kidney Benefits Beyond Weight Loss

GLP-1 Agonists: Heart & Kidney Benefits Beyond Weight Loss

Beyond Weight Loss: How GLP-1s Could Reshape the Future of Cardiovascular & Kidney Health Imagine a future where a single medication not only helps manage obesity but also significantly reduces your risk of heart attack and kidney failure. It’s not science fiction. Emerging research suggests that GLP-1 receptor agonists – initially hailed as breakthrough weight-loss … Read more

Spinal Cord Infarction: TACE & HCC – A Rare Case Report

The Rising Risk of Spinal Cord Infarction Post-Hepatocellular Carcinoma Treatment: What the Future Holds Imagine a scenario: a patient, relieved to have undergone successful transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC), suddenly experiences debilitating weakness and sensory loss. While TACE is a vital treatment for liver cancer, a growing body of evidence, highlighted by recent … Read more

Antimicrobial Resistance: Global Trends & Projections

The Looming Threat Beyond Antibiotics: Why Current Resistance Estimates May Be Vastly Understated Every year, an estimated 1.27 million deaths globally are directly attributable to antibiotic-resistant infections. But a recent, comprehensive analysis suggests that number is a significant undercount – potentially by millions. While the GBD 2021 Antimicrobial Resistance Collaborators’ work is a crucial step … Read more